Brexpiprazole as a new approach of treatment in somatization disorder
Introduction: Somatic symptom disorder (SSD) is a mental disorder that involves one or more physical symptoms (e.g. palpitations, dizziness, diarrhoea, limb weakness, pain, and pseudo neurological symptoms) accompanied by one or more thoughts, feelings, and/or behaviours related to the somatic sympt...
Main Authors: | Stefania Chiappini, Alessio Mosca, Giovanni Martinotti, Francesco Di Carlo, Andrea Miuli, Luigi Dattoli, Mauro Pettorruso, Massimo Di Giannantonio |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Emerging Trends in Drugs, Addictions, and Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667118222000010 |
Similar Items
-
Impressive Response with Brexpiprazole in Ekbom’s syndrome
by: J. Hsiao, et al.
Published: (2022-06-01) -
Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems
by: Kouji Fukuyama, et al.
Published: (2022-06-01) -
Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary study
by: Yusuke Arai, et al.
Published: (2023-03-01) -
Subjective assessment of brexpiprazole in patients with schizophrenia: a prospective observational study
by: Rina Yokoi, et al.
Published: (2023-08-01) -
Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication)
by: Jun Ishigooka, et al.
Published: (2020-06-01)